- Home
- PLD vs MDT Comparison
PLD vs MDT Comparison
Compare PLD & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLD | MDT |
|---|---|---|
| Founded | 1983 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7B | 131.9B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLD | MDT |
|---|---|---|
| Price | $138.72 | $99.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 19 |
| Target Price | ★ $135.29 | $110.29 |
| AVG Volume (30 Days) | 3.8M | ★ 9.1M |
| Earning Date | 01-21-2026 | 02-17-2026 |
| Dividend Yield | ★ 2.91% | 2.85% |
| EPS Growth | N/A | ★ 12.98 |
| EPS | 3.56 | ★ 3.69 |
| Revenue | $9,192,658,000.00 | ★ $34,758,000,000.00 |
| Revenue This Year | $2.11 | $8.58 |
| Revenue Next Year | $5.97 | $5.88 |
| P/E Ratio | $39.06 | ★ $26.96 |
| Revenue Growth | ★ 7.45 | 5.34 |
| 52 Week Low | $85.35 | $79.55 |
| 52 Week High | $141.95 | $106.33 |
Technical Indicators
Market Signals| Indicator | PLD | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 62.38 | 57.56 |
| Support Level | $135.62 | $98.62 |
| Resistance Level | $141.95 | $105.50 |
| Average True Range (ATR) | 2.80 | 2.12 |
| MACD | 0.65 | -0.12 |
| Stochastic Oscillator | 75.69 | 52.69 |
Price Performance
Historical ComparisonAbout PLD Prologis Inc.
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1.3 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $60 billion of third-party assets under management. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.